VCYT (Veracyte) Bathi resik saben saham (EPS TTM)

VCYT (Veracyte Corp) - tandha merek perusahaan

Under the leadership of Mark Staple, Veracyte, Inc. (VCYT) is implementing high-precision genomic tests, earning the absolute trust of oncologists by minimizing unnecessary surgeries. The rolling net income per share trend captures this success, where the value 1.55 records the final metric. Business growth is supported by stringent patent protections and insurance company recognition, creating an insurmountable barrier for new entrants.

VCYT Bathi saben saham sajrone rolas wulan pungkasan veracyte.com (04.07.2022 - 12.11.2026)

Rincian metrik lan analitis perusahaan Veracyte Inc (VCYT)

- kuotasi saiki lan rata-rata prakiraan nilai:
Bagan rega Veracyte, Inc.|VCYT - Prakiraan gabungan firma investasi
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Veracyte, Inc.|VCYT - Nilai Perusahaan
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Veracyte|VCYT - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih veracyte.com|VCYT - Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Veracyte, Inc.|VCYT - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Veracyte Corp|VCYT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Veracyte, Inc.|VCYT - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Veracyte|Rasio cepet veracyte.com
- data bathi lan kelipatan valuasi:
VCYT - Penghasilan resik perusahaan|Bathi sing dikarepake Veracyte, Inc.|VCYT - Nilai perusahaan marang bathi resik|Pangali Forward P/E Veracyte|VCYT - Pangali PEG|Pangali EV/EBITDA Veracyte, Inc.|VCYT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Veracyte|VCYT - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan veracyte.com|VCYT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Veracyte, Inc.
Analisis fundamental perusahaan:VCYT - Veracyte, Inc.
Produk seri Veracyte Inc

Biomaterial logistics and regulatory constraints in genomic diagnostics directly impact the operational efficiency of Veracyte, Inc. (VCYT), which is reflected in the rolling year net income per share trend. This indicator measures the final earnings attributable to a single share, allowing investors to assess the business's actual ability to generate profit regardless of the total capital volume.

Pesaing Veracyte, Inc.

CAI - Bathi saben saham sajrone rolas wulan pungkasan|GH (guardanthealth.com) - Bathi saben saham sajrone 12 wulan pungkasan|CELC: Bathi resik saben saham (EPS TTM)|GRAIL Inc (GRAL) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan Myriad Genetics Corp|Bathi saben saham sajrone rolas wulan pungkasan CSTL|Bathi resik saben saham sajrone 12 wulan pungkasan BNR (Burning Rock Biotech)|VNRX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Biodesix BDSX|Bathi resik saben saham sajrone patang kuartal pungkasan Precipio Inc. (PRPO)|Check-Cap Medical - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Mainz Biomed NV MYNZ|OncoCyte Corporation (OCX) - Bathi saben saham sajrone rolas wulan pungkasan